Teva Pharma (NYSE: TEVA) announced the launch of the generic equivalent of Lovenox® (enoxaparin sodium injection) in seven dosage strengths ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE